What caught my eye this week. Nobody asked for it and now it’s here – the new Monevator shop is open, offering in-joke themed investing T-shirts and vaguely punny sweatshirts to all. Perhaps you’ve already spotted Monevator members striding about town sporting fancy wares like this: Yes, those cool cats got early access. Thanks to everyone … Read more
The CJEU confirmed this morning in C‑339/22 BSH Hausgeräte GmbH v Electrolux AB (no language versions other than French and Swedish at the time of posting) that in principle Brussels Ia’s exclusive jurisdictional rule for registered intellectual property rights (A24(4) has no reflexive effect. [I suggest below that the reasoning extends to all of A24). … Read more
By Brad Sorensen, CFA NASDAQ:SCLX READ THE FULL SCLX RESEARCH REPORT Scilex Holding Company (NASDAQ:SCLX) is a revenue-generating company that is focused on addressing one of the biggest issues facing humanity today—that of the overuse of opioids. Scilex is focused on developing non-opioid pain management products that provide the relief patients so desperately need, while … Read more
Dexia v Patrimonio del Trentino [2024] EWHC 2717 (KB) echoes Banca Intesa v Venezia in some of its main issues. It features capacity of foreign corporations to enter into legal transaction, relevance of lex incorporationis, validity of choice of court clause, and the impact of Brexit, with the judge prima facie accepting resurrection of the … Read more
Seasoned former diplomat Kishore Mahbubani is a distinguished fellow at the National University of Singapore’s Asia Research Institute and author of nine books, including Has China Won? This interview first appeared in SCMP Plus. For other interviews in the Open Questions series, click here. You’ve predicted that the geopolitical contest between the US and China … Read more
